These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1196399)

  • 1. Effect of cortisol on serum creatine phosphokinase activity in disuse atrophy.
    Ahmad SB; Raina PN
    Naturwissenschaften; 1975 Jul; 62(7):353-4. PubMed ID: 1196399
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of hydrocortisone on the serum creatine kinase activity of muscles diseases.
    Cxyzewski K
    J Neurol; 1977 Nov; 216(4):283-7. PubMed ID: 72811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum creatine phosphokinase in motor neuron disease.
    Welch KM; Goldberg DM
    Neurology; 1972 Jul; 22(7):697-701. PubMed ID: 4673251
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter: Creatine phosphokinase as indicator of adenosine triphosphate activity.
    Sklar SH; Wigand JS
    JAMA; 1973 Dec; 226(12):1464-5. PubMed ID: 4800819
    [No Abstract]   [Full Text] [Related]  

  • 5. [Creatine phosphokinase: interpretation of the test results].
    Sugita H; Furukawa T; Chiba K
    Nihon Rinsho; 1969 Mar; ():Suppl:1072-7. PubMed ID: 4948291
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical significance of creatine kinase determination in myogenic and neurogenic muscular atrophy].
    Toczek-Dinehin M; Gulewicz E; Piechocki DW; Klimowicz H
    Wiad Lek; 1978 Jan; 31(1):39-43. PubMed ID: 654256
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunohistochemical study of creatine phosphokinase in pathological human muscle.
    Karpati G; Sherwin AL
    J Neurol Sci; 1971 Oct; 14(2):153-69. PubMed ID: 4939372
    [No Abstract]   [Full Text] [Related]  

  • 8. [The serum-creatine phosphokinase (CPK) activity in amyotrophic lateral sclerosis (ALS) and other neurogenous muscular atrophies with regard to differential diagnostic aspects].
    Koufen H; Consbruch U
    Nervenarzt; 1970 Dec; 41(12):599-603. PubMed ID: 4924032
    [No Abstract]   [Full Text] [Related]  

  • 9. Creatine phospholinase activity in spinal muscular atrophy.
    Hetnarska L; Prot J; Sawicka E
    J Neurol Sci; 1968; 6(2):261-7. PubMed ID: 4179110
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical biochemistry of atrophic muscular processes].
    Röthig HJ; Bernhardt W
    Acta Histochem Suppl; 1983; 28():119-23. PubMed ID: 6412286
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum-creatine-phosphokinase levels.
    Iwashita H; Ohta Y
    Lancet; 1967 Mar; 1(7490):621. PubMed ID: 4163988
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diagnostic value of the determination of creatine kinase activity and serum myoglobin concentration following graduated muscle stress].
    Weisner B; Kerrutt AM; Kunze K
    Nervenarzt; 1988 May; 59(5):278-85. PubMed ID: 3405345
    [No Abstract]   [Full Text] [Related]  

  • 13. Spinal muscular atrophy and hypertrophy of the calves.
    Bouwsma G; Van Wijngaarden GK
    J Neurol Sci; 1980 Jan; 44(2-3):275-9. PubMed ID: 7354373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum creatine kinase B subunit levels in neurogenic atrophies.
    Jockers-Wretou E; Vassilopoulos D
    J Neurol; 1985; 232(4):236-9. PubMed ID: 4045516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A temporal study of enzymes, isozymes, and histochemical changes in Duchenne's dystrophy and neurogenic atrophy.
    Hooshmand H
    Neurology; 1970 Apr; 20(4):409-10. PubMed ID: 5535061
    [No Abstract]   [Full Text] [Related]  

  • 16. Increased levels of serum-creatine-phosphokinase after transient limb ischaemia in patients with muscular dystrophy.
    Lanari A; González Pérez M; Semeniuk GB
    Lancet; 1970 Jan; 1(7640):217-8. PubMed ID: 4189011
    [No Abstract]   [Full Text] [Related]  

  • 17. Response of serum creatine phosphokinase to steroid hormone.
    Takahashi K; Oimomi M; Shinko T; Shutta K; Matsuo B
    Arch Neurol; 1975 Feb; 32(2):89-91. PubMed ID: 1122183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The significance of creatine phosphokinase determination in clinical practice].
    Sitzmann FC
    Med Klin; 1966 Aug; 61(32):1241-5. PubMed ID: 4871993
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum factors influencing creatine phosphokinase. In vitro studies using diffusates.
    Mascreen M; Biswakumar B; Valmikinathan K
    J Neurol Sci; 1975 Jul; 25(3):389-96. PubMed ID: 1159452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Creatine phosphokinase isoenzymes in human muscle biopsies].
    Magalhaes AS
    Acta Neurol Belg; 1970; 70(4):471-81. PubMed ID: 4992101
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.